Life Science Alley: R&D Makes German Medical Technologies Top in Europe
medical devices. Total industry revenue in 2007 amounted to
- a nearly 7 percent increase on 2006 figures. Investors looking to enter the
German and European markets can learn about
the largest convention of life science industry professionals in the American
Midwest. The conference takes place
Minnesota
the most renowned and trusted worldwide. The country’s advanced R&D network
ensures that both patients and practitioners have access to the latest
medical technologies.
Currently German medical technology companies spend about 9 percent of
sales revenue on R&D. As a result, products under three years old account for
32 percent of industry revenue in
in the world in patent applications in medical technologies.
Demographic developments suggest that
medical technologies in coming years. By 2015 it is expected that nearly one
fifth of
advanced medical technologies and health care.
Existing clusters of manufacturers, research institutes, and clinics
allow companies of all sizes the chance to use
conditions to maximize earnings quickly and efficiently. The availability of
investment incentives as well as R&D and labor incentives also makes the
country an attractive investment location.
Invest in
Federal Republic of
from site selection to the implementation of investment decisions. It can be
found at booth 301 at Life Science Alley.
Media Contact:
Eva Henkel
Phone: +49-30-200099-173
Fax: +49-30-200099-111
Email: henkel@invest-in-germany.com
SOURCE Invest in
